Jennifer Sheller

Jennifer Sheller is an accomplished leader in clinical trial operations, with extensive experience in various senior roles at prestigious pharmaceutical companies. At Merck, from March 2022 to December 2024, Jennifer served as Senior Vice President, Head of Global Clinical Trial Operations, and offered pivotal contributions as Vice President and Associate VP in clinical oversight and trial diversity. Prior experience includes leadership positions at Kyowa Hakko Kirin Pharma, Inc. and Sanofi, where Jennifer oversaw clinical operations in immunology and inflammation, as well as strategic management of clinical data and supplies. Jennifer began a career in clinical sciences as a Clinical Scientist at Wyeth Research and a Senior CRA at PharmaNet Development Group, Inc. Educational achievements comprise a BS in Molecular Biology from the University of Pittsburgh and two Master of Public Health degrees in Epidemiology from the University of Alabama at Birmingham.